Uni-Bio Science Group Limited reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was HKD 353.41 million compared to HKD 208.78 million a year ago. Net loss was HKD 19.59 million compared to HKD 71.32 million a year ago.

Basic loss per share from continuing operations was HKD 0.0031 compared to HKD 0.0111 a year ago. Diluted loss per share from continuing operations was HKD 0.0031 compared to HKD 0.0111 a year ago.